Explore
Trendline
Crystalys Therapeutics Initiates Phase 2 Trial for Gout Treatment with Dotinurad
Crystalys Therapeutics Initiates Phase 2 Trial for Gout Treatment with Dotinurad
Read More
Trendline
Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development
Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development
Read More
Trendline
DePuy Synthes Secures Exclusive Distribution for CGBIO's NOVOSIS in North America and Australia
DePuy Synthes Secures Exclusive Distribution for CGBIO's NOVOSIS in North America and Australia
Read More
Trendline
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Read More
Trendline
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in New York
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in New York
Read More
Trendline
FDA Classifies Eugia Pharma Specialities' Telangana Facility Inspection as Official Action Indicated
FDA Classifies Eugia Pharma Specialities' Telangana Facility Inspection as Official Action Indicated
Read More
SB Nation
Late Nite With Nola: Phillies 4, Padres 3
There was no musical guest, but it was still a good show.
Read More
Trendline
Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting
Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting
Read More
SB Nation
Castellanos’s “Eventful” Return: Phillies 3 Padres 0
They do not miss Nick Castellanos.
Read More
Trendline
AI-Driven Manufacturing Advances Enhance U.S. Healthcare Systems
AI-Driven Manufacturing Advances Enhance U.S. Healthcare Systems
Read More
SB Nation
Game 52: Athletics at San Diego Padres
Your game thread for May 24, 2026.
Read More
Trendline
Urban Micro Flower Farms Transform Neighborhoods with Community Engagement
Urban Micro Flower Farms Transform Neighborhoods with Community Engagement
Read More
